ENFN - Enfusion, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 620.22M
Enterprise Value 579.28M
Trailing P/E 206.50
Forward P/E 47.85
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.13
Price/Book (mrq)9.74
Enterprise Value/Revenue 3.69
Enterprise Value/EBITDA 48.44

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-25.92%
S&P500 52-Week Change 34.08%
52 Week High 316.76
52 Week Low 37.37
50-Day Moving Average 38.78
200-Day Moving Average 310.75

Share Statistics

Avg Vol (3 month) 3431.52k
Avg Vol (10 day) 3655.8k
Shares Outstanding 575.09M
Implied Shares Outstanding 6N/A
Float 822.73M
% Held by Insiders 17.36%
% Held by Institutions 1104.63%
Shares Short (May 14, 2023) 41.33M
Short Ratio (May 14, 2023) 43.66
Short % of Float (May 14, 2023) 44.00%
Short % of Shares Outstanding (May 14, 2023) 41.77%
Shares Short (prior month Apr 13, 2023) 41.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 1.63%
Operating Margin (ttm)3.24%

Management Effectiveness

Return on Assets (ttm)2.81%
Return on Equity (ttm)4.04%

Income Statement

Revenue (ttm)157.18M
Revenue Per Share (ttm)1.81
Quarterly Revenue Growth (yoy)20.00%
Gross Profit (ttm)103.25M
Net Income Avi to Common (ttm)2.54M
Diluted EPS (ttm)0.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)54.6M
Total Cash Per Share (mrq)0.73
Total Debt (mrq)13.65M
Total Debt/Equity (mrq)13.77
Current Ratio (mrq)6.32
Book Value Per Share (mrq)0.86

Cash Flow Statement

Operating Cash Flow (ttm)19.18M
Levered Free Cash Flow (ttm)13.03M